Summary
Endogenous isoquinolines with and without catechol structure have been proposed to be neurotoxins specific for dopamine neurons. In this paper they were examined for the cytotoxicity of human dopaminergic neuroblastoma SH-SY5Y cells. The cytotoxicity was quantitatively determined using Alamar Blue assay, by which the reduction-oxidation potency in the living cells can be measured spectrometrically. 1,2-Dimethyl-6,7-dihydroxyisoquinolinium ion [1,2-DMDHIQ+], an oxidation product of a parkinsonism-inducing isoquinoline, 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahyroisoquinoline [N-methyl-(R)salsolinol, NM(R)Sal] was found to be the most potent toxin among isoquinolines examined. In general, catechol isoquinolines were more toxic than isoquinolines without catechol structure. With and without catechol structure, the oxidized isoquinolinium ion having methyl groups at C-1 and N-2 positions proved to be more cytotoxic than the simple isoquinolines. The involvement of 1,2-DMDHIQ+ to the neurotoxicity of NM(R)Sal was suggested and discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahmed SA, Gogal RM Jr, Walsch JE (1994) A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immun Meth 170: 211–224
Bembenek ME, Abell CW, Chrisey LA, Rozwadowska MD, Gresner W, Brossi A (1990) Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-,3,4-dihydro-, and fully aromatic isoquinolines. J Med Chem 33: 147–152
Davis GCB, Williams AG, Markey SP, Ebert MH, Caine ED, Reichert Cw, Kopin IJ (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiat Res 1: 249–254
Deng Y, Maruyama W, Dostert P, Takahashi T, Kawai M, Naoi M (1995) Determination of the (R)- and (S)-enantiomers of salsolinol of N-methylsalsolinol by use of a chiral high-performance liquid Chromatographic column. J Chromatogr B 670: 47–54
Espinel-Ingroff A, Rodriguez-Tudela JL, Martinez-Suärez JV (1995) Comparison of two alternative microdilution procedures with the national committee for clinical laboratory standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans. J Clin Microbiol 33: 3154–3158
Johnson DE, Ochieng J, Evans SL (1995) The growth inhibitory properties of a dopamine agonist (SKF38393) on MCF-7 cells. Anti-Cancer Drugs 6: 471–474
Kajita M, Niwa T, Fujiaki M, Ueki M, Nimura K, Sato M, Egami K, Naoi M, Yoshida M, Nagatsu T (1995) Detection of 1-phenyl-N-methyl-1,2,3,4-tetrahydroisoquinoline and 1-phenyl-1,2,3,4-tetrahydroisoquinoline in human brain by gas chromatographytandem mass spectrometry. J Chromatogr B 669: 345–351
Maruyama W, Nakahara, D, Ota M, Takahashi A, Takahashi T, Nagatsu T, Naoi M (1992) N-Methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in the rat brains: in vivo microdialysis study. J Neurochem 59: 395–400
Maruyama W, Dostert P, Matsubara K, Naoi M (1995a) N-methyl(R)salsolinol produces hydroxyl radical: involvement to neurotoxicity. Free Rad Biol Med 19: 67–75
Maruyama W, Dostert P, Naoi M (1995b) Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: in vivo and in vitro studies. J Neurochem 64: 2635–2643
Maruyama W, Abe T, Tohgi H, Dostert P, Naoi M (1996) A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in parkinsonian cerebrospinal fluid. Ann Neurol 40: 119–122
McNaught KP, Thull U, Carrupt P-A, Altomare C, Cellamare S, Carotti A, Testa B, Jenner P, Marsden CD (1995) Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Biochem Pharmacol 50: 1903–1911
Nagatsu T, Yoshida M (1988) An endogenous substrate of brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci Lett 87: 178–182
Naoi M, Maruyama W, Zhang JH, Takahashi T, Deng Y, Dostert P (1995) Enzymatic oxidation of the dopaminergic neurotoxin, 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, into 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion. Life Sci 57: 1061–1066
Naoi M, Maruyama W, Dostert P, Hashizume Y, Nakahara D, Takahashi T, Ota M (1996a) Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies. Brain Res 709: 285–295
Naoi M, Maruyama W, Dostert P, Hashizume Y (1996b) Animal model of Parkinson's disease induced by naturally-occurring 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline. Biogen Amines 12: 135–147
Naoi M, Maruyama W, Dostert P, Kohda K, Kaiya T (1996c) A novel enzyme enantioselectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol. Neurosci Lett 212: 183–186
Naoi M, Maruyama W, Dostert P, Hashizume Y (1996d) N-Methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease. J Neural Transm [Suppl] 50 (in press)
Niwa T, Takeda N, Kaneda N, Hashizume Y, Nagatsu T (1987) Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains. Biochem Biophys Res Commun 144: 1084–1089
Niwa T, Takeda N, Yoshizumi H, Tatematsu A, Yoshida M, Dostert P, Naoi M, Nagatsu T (1991) Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brain. Biochem Biophys Res Commun 177: 603–609
Ohta S, Kohno M, Makino Y, Tachikawa O, Hirobe M (1987) Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline are present in the human brain: relation to Parkinson's disease. Biomed Res 8: 453–456
Pagë B, Pagë M, Noël C (1993) A new fluorometric assay for cytotoxicity measurements in vitro. Int J Oncol 3: 471–476
Pfaller MA, Barry AL (1994) Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol 32: 1992–1996
Pfaller MA, Grant C, Morthland V, Rhine-Chalberg JR (1994) Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans. J Clin Microbiol 32: 506–509
Sjöquist B, Eriksson A, Winlad B (1982) Salsolinol and catecholamines in human brain and their relation to alcoholims. Prog Clin Biol Res 90: 57–67
Strolin Benedetti M, Bellotti V, Planezola E, Moro E, Carminat P, Dostert P (1989) Ratio of the R and S enantiomers of salsolinol in food and human urine. J Neural Transm 77: 47–53
Suzuki K, Mizuno Y, Yamauchi Y, Nagatsu T, Yoshida M (1992) Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain. J Neurol Sci 109: 219–223
Takahashi T, Deng Y, Maruyama W, Dostert P, Kawai M, Naoi M (1994) Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system. J Neural Transm [Gen Sect] 98: 107–118
Tasaki Y, Makino M, Ohta S, Hirobe M (1991) 1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavioral abnormalities. J Neurochem 57: 1940–1943
Teitel S, O'Brien J, Brossi A (1972) Alkaloids in mammalian tissues. II. Synthesis of (+) and (−) substituted 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines. J Med Chem 15: 845–846
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takahashi, T., Maruyama, W., Deng, Y. et al. Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells. J. Neural Transmission 104, 59–66 (1997). https://doi.org/10.1007/BF01271294
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01271294